Physician profile
Jamil A Malik
NPI 1760457469
$74,354.95
in general payments reported to CMS, 2019-2025
43 companies · $3,602 in 2025
The $3,602 reported for 2025 was more than what 78% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,288 · 2021: $17K · 2022: $21K · 2023: $6,464 · 2024: $4,322 · 2025: $3,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,852 · Food and Beverage: $6,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,852.00 |
| Food and Beverage | $6,535.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $47,160.58 | 2019-2025 | Kengreal |
| Abiomed | $16,413.45 | 2019-2025 | Impella |
| Biotronik INC. | $1,905.00 | 2019 | |
| Heartflow, INC. | $1,206.55 | 2022-2025 | Ffrct |
| Osprey Medical INC | $790.24 | 2019-2020 | |
| Medtronic Vascular, INC. | $735.38 | 2019-2020 | |
| Inari Medical, INC. | $656.93 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sirtex Medical INC | $550.00 | 2019 | |
| Boston Scientific Corporation | $504.67 | 2022-2025 | Watchman Flx, Avvigo Guidance System, Watchman Access System |
| Abbott Laboratories | $490.47 | 2019-2024 | Cardiomems, Mitraclip |
| Teleflex LLC | $335.57 | 2019-2024 | Trapliner |
| Stryker Corporation | $320.13 | 2025 | Artix Mt |
| Novartis Pharmaceuticals Corporation | $309.18 | 2019-2025 | |
| Medtronic, INC. | $285.08 | 2021-2023 | Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $268.96 | 2023-2025 | Lifevest |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $244.76 | 2022-2023 | |
| Shockwave Medical, INC | $240.82 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $235.61 | 2019-2021 | |
| Ekos Corporation | $201.43 | 2019 | |
| Acist Medical Systems, INC. | $168.85 | 2022-2024 | |
| Cardiva Medical, INC. | $167.09 | 2022 | |
| Janssen Pharmaceuticals, INC | $164.01 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $156.20 | 2020-2024 | Farxiga |
| Angiodynamics, INC. | $142.97 | 2023 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $125.88 | 2022-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.15 | 2020-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $94.55 | 2021-2023 | Verquvo |
| Cvrx, INC. | $89.44 | 2023-2024 | Barostim Neo System |
| Livanova USA, INC. | $45.16 | 2019 | |
| Sanofi-Aventis U.S. LLC | $34.16 | 2019-2020 | |
| Esperion Therapeutics, INC. | $34.14 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $31.07 | 2024 | Arcalyst |
| Avinger INC. | $26.79 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $25.21 | 2025 | Evkeeza, Praluent |
| Lexicon Pharmaceuticals, INC. | $18.83 | 2024 | |
| Impulse Dynamics (USA) INC. | $16.13 | 2022 | |
| Glaxosmithkline, LLC. | $15.79 | 2025 | Arexvy, Shingrix |
| Agepha Pharma Fz LLC | $15.63 | 2024 | Lodoco |
| Pfizer INC. | $15.31 | 2022 | |
| Cook Medical LLC | $12.78 | 2023 | Evolution |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamil Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.